Suppr超能文献

Naproxen in the treatment of OC-resistant primary dysmenorrhea. A double-blind cross-over study.

作者信息

Jacobson J, Lundström V, Nilsson B

出版信息

Acta Obstet Gynecol Scand Suppl. 1983;113:87-9. doi: 10.3109/00016348309155206.

Abstract

The efficacy of oral contraceptives (OC) in the treatment of primary dysmenorrhea in controlled studies varies from 50 to 80%. The addition of a prostaglandin synthetase inhibitor, naproxen, was found to afford pain relief to a further 70% of women with OC-resistant dysmenorrhea in a double-blind cross-over study comprising 39 patients. This effect was shown to be statistically significant at p = 0.0005. Our recommendation is that low-dose OCs should be the first choice as contraceptive agents for women with dysmenorrhea and that a prostaglandin synthetase inhibitor should be given when OCs are ineffective.

摘要

相似文献

1
Naproxen in the treatment of OC-resistant primary dysmenorrhea. A double-blind cross-over study.
Acta Obstet Gynecol Scand Suppl. 1983;113:87-9. doi: 10.3109/00016348309155206.
5
Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors--a promising therapeutic alternative.
Acta Obstet Gynecol Scand. 1978;57(5):421-8. doi: 10.3109/00016347809156523.
7
Diflunisal compared with naproxen in the treatment of dysmenorrhea.
Prostaglandins Leukot Med. 1984 Aug;15(2):153-8. doi: 10.1016/0262-1746(84)90172-0.
8
Clinical experience of naproxen in the treatment of primary dysmenorrhea.
Acta Obstet Gynecol Scand Suppl. 1979;87:95-100. doi: 10.3109/00016347909157800.
9
Comparison between naproxen tablets and suppositories in primary dysmenorrhea.
Prostaglandins. 1980 Sep;20(3):463-8. doi: 10.1016/0090-6980(80)90033-7.
10
Naproxen and indomethacin in the treatment of primary dysmenorrhea.
Acta Obstet Gynecol Scand Suppl. 1979;87:87-9. doi: 10.3109/00016347909157797.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验